Market
How will Lula da Silva's approval ratings change by March 31, 2025?
4
Resolution / Starting Odds
Increase • 25%
Decrease • 25%
Remain stable • 25%
Insufficient data • 25%
Opinion polls conducted by recognized Brazilian polling agencies
Story
Brazil's President Lula Undergoes Successful Embolization Surgery to Prevent Brain Bleeding
Dec 12, 2024, 10:53 AM
Brazilian President Luiz Inácio Lula da Silva underwent a successful second surgical procedure on Thursday to prevent future intracranial bleeding, following an emergency operation earlier this week to address a brain hemorrhage caused by a fall in October. The procedure, an embolization of the middle meningeal artery, was performed by his medical team at the Sirio-Libanês Hospital in São Paulo and lasted less than an hour. Lula's personal doctor, Roberto Kalil Filho, confirmed that the procedure was successful and that the president is awake, lucid, and conversing. The intervention was planned to minimize the risk of future bleeding and is considered low-risk.
View original story
Similar markets
Below 40% • 25%
40%-50% • 25%
Above 60% • 25%
50%-60% • 25%
Between 20% and 40% • 25%
Below 20% • 25%
Above 60% • 25%
Between 40% and 60% • 25%
Below 40% • 25%
Above 60% • 25%
50% - 60% • 25%
40% - 49% • 25%
Below 40% • 25%
40% to 49% • 25%
50% to 60% • 25%
Above 60% • 25%
Above 60% • 25%
Below 40% • 25%
40% to 49% • 25%
50% to 60% • 25%
Improved perception • 25%
Other • 25%
Worsened perception • 25%
Unchanged perception • 25%
Other • 25%
Decrease • 25%
Increase • 25%
No Change • 25%
Unchanged support for Lula • 25%
Significant political unrest • 25%
Increased support for Lula • 25%
Decreased support for Lula • 25%
Calls for leadership change • 25%
Increased political stability • 25%
Increased political uncertainty • 25%
No significant impact • 25%
Positive impact with increased support • 25%
Mixed reactions • 25%
No significant change in public perception • 25%
Negative impact with decreased support • 25%
Partial recovery with ongoing treatment • 25%
Full recovery • 25%
Other outcomes • 25%
Significant health decline • 25%
Neutral • 25%
Negative • 25%
Positive • 25%
Mixed • 25%